Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Balancing Trained Immunity with Persistent Immune Activation and the Risk of Simian Immunodeficiency Virus Infection in Infant Macaques Vaccinated with Attenuated Mycobacterium tuberculosis or Mycobacterium bovis BCG Vaccine.

Jensen K, Dela Pena-Ponce MG, Piatak M Jr, Shoemaker R, Oswald K, Jacobs WR Jr, Fennelly G, Lucero C, Mollan KR, Hudgens MG, Amedee A, Kozlowski PA, Estes JD, Lifson JD, Van Rompay KK, Larsen M, De Paris K.

Clin Vaccine Immunol. 2017 Jan 5;24(1). pii: e00360-16. doi: 10.1128/CVI.00360-16. Print 2017 Jan.

2.

Vaccine-Elicited Mucosal and Systemic Antibody Responses Are Associated with Reduced Simian Immunodeficiency Viremia in Infant Rhesus Macaques.

Jensen K, Nabi R, Van Rompay KKA, Robichaux S, Lifson JD, Piatak M Jr, Jacobs WR Jr, Fennelly G, Canfield D, Mollan KR, Hudgens MG, Larsen MH, Amedee AM, Kozlowski PA, De Paris K.

J Virol. 2016 Jul 27;90(16):7285-7302. doi: 10.1128/JVI.00481-16. Print 2016 Aug 15.

3.

Baylisascaris procyonis and Herpes Simplex Virus 2 Coinfection Presenting as Ocular Larva Migrans with Granuloma Formation in a Child.

Liu G, Fennelly G, Kazacos KR, Grose C, Dobroszycki J, Saffra N, Coyle CM, Weiss LM, Szlechter MM, Tanowitz HB.

Am J Trop Med Hyg. 2015 Sep;93(3):612-4. doi: 10.4269/ajtmh.15-0272. Epub 2015 Jun 29.

4.

A neonatal oral Mycobacterium tuberculosis-SIV prime / intramuscular MVA-SIV boost combination vaccine induces both SIV and Mtb-specific immune responses in infant macaques.

Jensen K, Pena MG, Wilson RL, Ranganathan UD, Jacobs WR Jr, Fennelly G, Larsen M, Van Rompay KK, Kozlowski PA, Abel K.

Trials Vaccinol. 2013 Nov 1;2:53-63.

5.

A recombinant attenuated Mycobacterium tuberculosis vaccine strain is safe in immunosuppressed simian immunodeficiency virus-infected infant macaques.

Jensen K, Ranganathan UD, Van Rompay KK, Canfield DR, Khan I, Ravindran R, Luciw PA, Jacobs WR Jr, Fennelly G, Larsen MH, Abel K.

Clin Vaccine Immunol. 2012 Aug;19(8):1170-81. doi: 10.1128/CVI.00184-12. Epub 2012 Jun 13.

6.

Association of differentiation state of CD4+ T cells and disease progression in HIV-1 perinatally infected children.

Sharp ER, Willberg CB, Kuebler PJ, Abadi J, Fennelly GJ, Dobroszycki J, Wiznia AA, Rosenberg MG, Nixon DF.

PLoS One. 2012;7(1):e29154. doi: 10.1371/journal.pone.0029154. Epub 2012 Jan 11.

7.

Immunodominance of HIV-1 specific CD8+ T-cell responses is related to disease progression rate in vertically infected adolescents.

Sharp ER, Willberg CB, Kuebler PJ, Abadi J, Fennelly GJ, Dobroszycki J, Wiznia AA, Rosenberg MG, Nixon DF.

PLoS One. 2011;6(7):e21135. doi: 10.1371/journal.pone.0021135. Epub 2011 Jul 19.

9.

Recombinant pro-apoptotic Mycobacterium tuberculosis generates CD8+ T cell responses against human immunodeficiency virus type 1 Env and M. tuberculosis in neonatal mice.

Ranganathan UD, Larsen MH, Kim J, Porcelli SA, Jacobs WR Jr, Fennelly GJ.

Vaccine. 2009 Dec 10;28(1):152-61. doi: 10.1016/j.vaccine.2009.09.087. Epub 2009 Oct 4.

10.

Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG.

Bueno SM, González PA, Cautivo KM, Mora JE, Leiva ED, Tobar HE, Fennelly GJ, Eugenin EA, Jacobs WR Jr, Riedel CA, Kalergis AM.

Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20822-7. doi: 10.1073/pnas.0806244105. Epub 2008 Dec 15.

11.

Child care-associated outbreak of Escherichia coli O157:H7 and hemolytic uremic syndrome.

Raffaelli RM, Paladini M, Hanson H, Kornstein L, Agasan A, Slavinski S, Weiss D, Fennelly GJ, Flynn JT.

Pediatr Infect Dis J. 2007 Oct;26(10):951-3.

PMID:
17901803
12.

Natural killer cells in perinatally HIV-1-infected children exhibit less degranulation compared to HIV-1-exposed uninfected children and their expression of KIR2DL3, NKG2C, and NKp46 correlates with disease severity.

Ballan WM, Vu BA, Long BR, Loo CP, Michaëlsson J, Barbour JD, Lanier LL, Wiznia AA, Abadi J, Fennelly GJ, Rosenberg MG, Nixon DF.

J Immunol. 2007 Sep 1;179(5):3362-70.

13.

Genetic alteration of Mycobacterium smegmatis to improve mycobacterium-mediated transfer of plasmid DNA into mammalian cells and DNA immunization.

Mo Y, Quanquin NM, Vecino WH, Ranganathan UD, Tesfa L, Bourn W, Derbyshire KM, Letvin NL, Jacobs WR Jr, Fennelly GJ.

Infect Immun. 2007 Oct;75(10):4804-16. Epub 2007 Jul 30.

14.

Partial treatment interruption of protease inhibitor-based highly active antiretroviral therapy regimens in HIV-infected children.

Abadi J, Sprecher E, Rosenberg MG, Dobroszycki J, Sansary J, Fennelly G, Wiznia A.

J Acquir Immune Defic Syndr. 2006 Mar;41(3):298-303.

PMID:
16540930
15.

Generation of CD8+ T-cell responses by a recombinant nonpathogenic Mycobacterium smegmatis vaccine vector expressing human immunodeficiency virus type 1 Env.

Cayabyab MJ, Hovav AH, Hsu T, Krivulka GR, Lifton MA, Gorgone DA, Fennelly GJ, Haynes BF, Jacobs WR Jr, Letvin NL.

J Virol. 2006 Feb;80(4):1645-52.

16.

Partial treatment interruption of protease inhibitors augments HIV-specific immune responses in vertically infected pediatric patients.

Legrand FA, Abadi J, Jordan KA, Davenport MP, Deeks SG, Fennelly GJ, Wiznia AA, Nixon DF, Rosenberg MG.

AIDS. 2005 Oct 14;19(15):1575-85.

PMID:
16184026
17.

Mucosal immunization with attenuated Shigella flexneri harboring an influenza hemagglutinin DNA vaccine protects mice against a lethal influenza challenge.

Vecino WH, Quanquin NM, Martinez-Sobrido L, Fernandez-Sesma A, García-Sastre A, Jacobs WR Jr, Fennelly GJ.

Virology. 2004 Aug 1;325(2):192-9.

18.
19.

HIV-specific CD8+ T cell function in children with vertically acquired HIV-1 infection is critically influenced by age and the state of the CD4+ T cell compartment.

Sandberg JK, Fast NM, Jordan KA, Furlan SN, Barbour JD, Fennelly G, Dobroszycki J, Spiegel HM, Wiznia A, Rosenberg MG, Nixon DF.

J Immunol. 2003 Apr 15;170(8):4403-10.

20.

Nontyphoidal salmonella bacteremia and pneumonia as the initial manifestation of human immunodeficiency virus infection in a four-year-old child.

Eaton EE, Dobrozycski J, Loas R, Laddis D, Fennelly GJ.

AIDS Patient Care STDS. 2002 Jun;16(6):247-50.

PMID:
12133259
21.

Selective loss of innate CD4(+) V alpha 24 natural killer T cells in human immunodeficiency virus infection.

Sandberg JK, Fast NM, Palacios EH, Fennelly G, Dobroszycki J, Palumbo P, Wiznia A, Grant RM, Bhardwaj N, Rosenberg MG, Nixon DF.

J Virol. 2002 Aug;76(15):7528-34.

22.

Mucosal DNA vaccination with highly attenuated Shigella is superior to attenuated Salmonella and comparable to intramuscular DNA vaccination for T cells against HIV.

Vecino WH, Morin PM, Agha R, Jacobs WR Jr, Fennelly GJ.

Immunol Lett. 2002 Jul 3;82(3):197-204. Erratum in: Immunol Lett. 2004 Feb 15;91(2-3):256.

PMID:
12036602
23.
24.

The impact of early initiation of highly active antiretroviral therapy on the human immunodeficiency virus type 1-specific CD8 T cell response in children.

Spiegel HM, Chandwani R, Sheehy ME, Dobroszycki J, Fennelly G, Wiznia A, Radding J, Rigaud M, Pollack H, Borkowsky W, Rosenberg M, Nixon DF.

J Infect Dis. 2000 Jul;182(1):88-95. Epub 2000 Jun 27.

PMID:
10882585
25.

Endocardial abscesses in children: case report and review of the literature.

Shah FS, Fennelly G, Weingarten-Arams J, Yang L, Glickstein J.

Clin Infect Dis. 1999 Dec;29(6):1478-82. Review.

PMID:
10585799
26.

Mucosal DNA vaccine immunization against measles with a highly attenuated Shigella flexneri vector.

Fennelly GJ, Khan SA, Abadi MA, Wild TF, Bloom BR.

J Immunol. 1999 Feb 1;162(3):1603-10.

27.

Updates on measles vaccine.

Adam HM, Fennelly GJ.

Pediatr Rev. 1998 Sep;19(9):323. No abstract available.

PMID:
9745318
28.

Measles vaccine.

Fennelly GJ.

Pediatr Rev. 1998 May;19(5):178-9. No abstract available.

PMID:
9584533
29.

Recombinant bacille Calmette-Guérin expressing the measles virus nucleoprotein protects infant rhesus macaques from measles virus pneumonia.

Zhu YD, Fennelly G, Miller C, Tarara R, Saxe I, Bloom B, McChesney M.

J Infect Dis. 1997 Dec;176(6):1445-53.

PMID:
9395353
30.

Recombinant bacille Calmette-Guérin priming against measles.

Fennelly GJ, Flynn JL, ter Meulen V, Liebert UG, Bloom BR.

J Infect Dis. 1995 Sep;172(3):698-705.

PMID:
7658061

Supplemental Content

Loading ...
Support Center